ebomi
Colour theme
Sign in
Insider · CIK 0001262327

Lawlor Augustine

CIK 0001262327 Name as filed on the most recent filing

Filed as Lawlor Augustine (24)

37 transaction lines · from 24 filings · filed 2004-06-02 to 2020-02-25 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

20 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-02-25 S, Open-market sale Catalyst Biosciences, Inc.CBIO 423,506, disposed Open Form 4 filing 0001209191-20-012454
2019-02-05 P, Open-market purchase Leap Therapeutics, Inc.LPTX 999,999, acquired Open Form 4 filing 0001104659-19-005837
2017-11-14 P, Open-market purchase Leap Therapeutics, Inc.LPTX 6,436,524, acquired Open Form 4 filing 0001104659-17-069118
2016-03-18 S, Open-market sale Globeimmune IncGBIM 17,050, disposed Open Form 4 filing 0001209191-16-109559
2016-03-15 S, Open-market sale Globeimmune IncGBIM 5,125, disposed Open Form 4 filing 0001209191-16-109205
2016-03-11 S, Open-market sale Globeimmune IncGBIM 26,080, disposed Open Form 4 filing 0001209191-16-108196
2016-03-10 S, Open-market sale Globeimmune IncGBIM 270, disposed Open Form 4 filing 0001209191-16-108196
2016-03-08 S, Open-market sale Globeimmune IncGBIM 5,500, disposed Open Form 4 filing 0001209191-16-107020
2016-03-07 S, Open-market sale Globeimmune IncGBIM 4,960, disposed Open Form 4 filing 0001209191-16-107020
2016-03-04 S, Open-market sale Globeimmune IncGBIM 5,250, disposed Open Form 4 filing 0001209191-16-107020
2016-03-03 S, Open-market sale Globeimmune IncGBIM 1,139, disposed Open Form 4 filing 0001209191-16-105458
2016-03-02 S, Open-market sale Globeimmune IncGBIM 11,900, disposed Open Form 4 filing 0001209191-16-105458
2016-03-01 S, Open-market sale Globeimmune IncGBIM 4,700, disposed Open Form 4 filing 0001209191-16-105458
2016-02-29 S, Open-market sale Globeimmune IncGBIM 4,450, disposed Open Form 4 filing 0001209191-16-103474
2016-02-26 S, Open-market sale Globeimmune IncGBIM 5,000, disposed Open Form 4 filing 0001209191-16-103474
2016-02-25 S, Open-market sale Globeimmune IncGBIM 5,250, disposed Open Form 4 filing 0001209191-16-103474
2016-02-24 S, Open-market sale Globeimmune IncGBIM 5,850, disposed Open Form 4 filing 0001209191-16-101999
2016-02-23 S, Open-market sale Globeimmune IncGBIM 6,950, disposed Open Form 4 filing 0001209191-16-101999
2016-02-22 S, Open-market sale Globeimmune IncGBIM 7,150, disposed Open Form 4 filing 0001209191-16-101999
2016-02-19 S, Open-market sale Globeimmune IncGBIM 6,950, disposed Open Form 4 filing 0001209191-16-100441
2016-02-18 S, Open-market sale Globeimmune IncGBIM 7,000, disposed Open Form 4 filing 0001209191-16-100441
2016-02-17 S, Open-market sale Globeimmune IncGBIM 7,650, disposed Open Form 4 filing 0001209191-16-100441
2016-02-17 P, Open-market purchase Proteostasis Therapeutics, Inc.PTI 3,000,000, acquired Open Form 4 filing 0000899243-16-013608
2016-02-16 S, Open-market sale Globeimmune IncGBIM 7,550, disposed Open Form 4 filing 0001209191-16-098769
2016-02-12 S, Open-market sale Globeimmune IncGBIM 7,950, disposed Open Form 4 filing 0001209191-16-098769
2016-02-11 S, Open-market sale Globeimmune IncGBIM 8,600, disposed Open Form 4 filing 0001209191-16-098769
2014-08-21 S, Open-market sale Cardiovascular Systems IncCSII 10,132,642, disposed Open Form 4 filing 0000914190-14-000375
2014-07-08 P, Open-market purchase Globeimmune IncGBIM 1,900,000, acquired Open Form 4 filing 0001209191-14-046450
2014-02-05 P, Open-market purchase Trevena IncTRVN 2,079,406, acquired Open Form 4 filing 0001209191-14-008252
2013-12-17 P, Open-market purchase Tetralogic Pharmaceuticals CorpTLOG 4,994,241, acquired Open Form 4 filing 0001209191-13-057535
2009-10-05 P, Open-market purchase Threshold Pharmaceuticals IncTHLD Not reported Open Form 4 filing 0001209191-09-048013
2007-08-03 P, Open-market purchase Pharmathene, IncHAQ 957,500, acquired Open Form 4 filing 0001231919-07-000111
2007-08-03 P, Open-market purchase Healthcare Acquisition CorpHAQ 957,500, acquired Open Form 4 filing 0001231919-07-000065
2007-08-03 P, Open-market purchase Activbiotics IncHAQ 957,500, acquired Open Form 4 filing 0001231919-07-000064
2007-04-12 P, Open-market purchase Advancis Pharmaceutical CorpAVNC 1,614,178, acquired Open Form 4 filing 0001231919-07-000029
2004-06-02 P, Open-market purchase Critical Therapeutics IncCRTX 2,499,700, acquired Open Form 4 filing 0001231919-04-000200
2004-06-02 P, Open-market purchase Critical Therapeutics IncCRTX 2,499,700, acquired Open Form 4 filing 0001231919-04-000175

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 18
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. LAWLOR AUGUSTINE, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001262327

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.